Clinical Trial Update: Clemastine Treatment in Individuals With Williams Syndrome [Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 2 study of clemastine for Williams syndrome is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Williams Syndrome

Drugs mentioned

• Clemastine (clemastine)

Snippet

Sponsor: Sheba Medical Center | Conditions: Williams Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING